Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

PublicNASDAQ:NSPH
Date11/2007
Raised
Post IPO Valuation

General Information

Websitenanosphere.us
Twitter@nanosphere
CategoryBioTech
Phone1-888-VERIGENE (837-4436)
Employees
Founded1999
DescriptionDiagnostic tests personalized medicine

Offices

Northbrook, USA
4088 Commercial Avenue
Northbrook, IL, 60062
USA

People

President and Chief Executive Officer & Board of Directors
Vice President of Finance, Treasurer and Chief Financial Officer
Board of Directors
Board of Directors
Board of Directors
Board of Directors
Board of Directors
Chief Strategy Officer

Funding

TOTAL $30.2M
POST IPO FUNDING TOTAL $30.2M
Post IPO Equity, 9/2013
$30.2M

Tags

Nanosphere

Nanosphere, Inc. is a nanotechnology-based healthcare company, making clinical diagnostic tests that are two to three times as sensitive as those commonly used in hospital labs today and much simpler, taking just hours rather than days or weeks to complete. The company’s instruments, which use microfluidics to pull DNA and proteins from a sample, detect genetic variations in blood that make some drugs more effective in some patients than others. The key is an array of gold nanoparticles studded with chemicals that capture characteristic proteins and nucleic acids from clinical samples such as blood.

Recent Milestones

Videos

Screenshots

Nanosphere screenshot
Above: Homepage
Uploaded: 9/19/13

Stock Price

Sources

  1. Nanosphere snags $30.2M in stock sale (fiercemedicaldevices.com) [edit]
Edit This Page
Last Edited 4/4/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy